A search of the NIH ClinicalTrials.gov database [126] for clinical trials on cell cycle checkpoint inhibitors in brain tumors identified two trials on inhibitors of ATM and CHK1, respectively, and five on the WEE1 inhibitor AZD1775 (Table 2). Here, WEE1 is linked to brain neoplasm.